Vadivarhe Speciality Chemicals Ltd.
•Add ratio to table
ABOUT
KEY POINTS
Revenue Breakup Mar 2013 • Speciality Chemicals: 84.9% • Neutraceuticals Products: 15.1%
AI Sector View
AI GENERATEDChemicals
The available domestic chemical proxies are mixed to weak. Fertilizers output was -8.0% YoY (2026-07) and sale quantity of fertilisers was 0.0% YoY (2026-05), although that high-frequency barometer is stale. FPI positioning is less negative than before, with net 3-month outflow only INR -11 crore versus INR -1229 crore in the prior 3 months to 2026-08-31, but the weak sector driver argues for a neutral stance.
PROS
- Company is almost debt free
- Operating margins have improved to -16.1% from -29.7%
- Working capital cycle has improved - days down from 20 to -22
CONS
- Company is loss-making at the operating / net level
- Net worth is negative - accumulated losses have eroded equity
- Operating cash flow has been negative in recent years
- Company has a low return on equity of -159.5% over last 3 years
- Receivables are growing faster than sales - a possible quality concern
- Company has a low return on capital employed of -1.4%
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
| Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| SOLARINDS | 21410.70 | 97.29 | 193745.54 | 0.05 | 666.37 | 88.98 | 3668.20 | 70.26 | 38.16 | 27.91 |
| PIDILITIND | 1632.00 | 62.71 | 166117.97 | 1.32 | 8835.10 | 1202.86 | 45515.50 | 1112.74 | 32.38 | 26.28 |
| SRF | 2605.00 | 35.72 | 77218.67 | 0.35 | 758.87 | 75.53 | 5033.26 | 34.63 | 14.21 | 24.57 |
| FLUOROCHEM | 4691.60 | 83.80 | 51537.23 | 0.06 | 219.00 | 19.02 | 1588.00 | 23.97 | 9.58 | 26.83 |
| NAVINFLUOR | 8697.20 | 56.51 | 44623.69 | 0.17 | 243.31 | 107.67 | 1045.08 | 44.07 | 21.39 | 34.17 |
| GODREJIND | 1155.90 | 33.12 | 38936.61 | 0.00 | 523.36 | -27.85 | 5448.09 | 22.16 | 10.64 | 12.82 |
| DEEPAKNTR | 1727.25 | 30.08 | 23558.49 | 0.43 | 345.01 | 207.36 | 2577.60 | 36.39 | 11.58 | 20.96 |
| AETHER | 1656.35 | 93.47 | 21984.38 | 0.00 | 62.75 | 33.45 | 326.56 | 27.49 | 11.65 | 31.47 |
| ATUL | 6465.50 | 23.93 | 19035.57 | 0.46 | 253.93 | 91.85 | 1847.95 | 25.03 | 15.05 | 21.41 |
| AARTIIND | 501.75 | 34.27 | 18199.81 | 0.20 | 155.00 | 260.47 | 2387.00 | 42.42 | 6.95 | 16.00 |
| DEEPAKFERT | 1356.30 | 17.46 | 17179.29 | 0.74 | 490.04 | 100.95 | 3256.26 | 22.47 | 12.12 | 25.96 |
| VSCL | 21.95 | 0.00 | 32.92 | 0.00 | — | — | — | — | -22.89 | — |
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
No standalone quarterly results found
We don't have this information yet. Please check back later.
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 35 | 26 | 32 | 30 | 26 | 21 | 44 | 40 | 38 | |
| 19 | 25 | 22 | 30 | 39 | 27 | 28 | 41 | 36 | 44 | |
| Operating Profit | 7 | 10 | 4 | 2 | -9 | -1 | -7 | 3 | 4 | -6 |
| OPM % | 28.12% | 29.69% | 14.74% | 7.18% | -30.66% | -2.33% | -32.29% | 7.02% | 11.03% | -16.11% |
| 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 |
| Depreciation | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Profit before Tax | 5 | 9 | 2 | 0 | -12 | -3 | -10 | 1 | 2 | -9 |
| Tax % | 36.15% | 36.44% | 18.62% | -17.23% | 17.90% | -6.54% | -0.00% | 0.00% | 95.92% | -0.00% |
| Net Profit | 3 | 6 | 2 | 0 | -10 | -3 | -10 | 1 | 0 | -9 |
| EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -2.16 | -8.00 | 0.90 | 0.05 | -7.25 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
COMPOUNDED SALES GROWTH
- 10 Years:
- 7%
- 5 Years:
- 5%
- 3 Years:
- 21%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- -10%
- 3 Years:
- -21%
- 1 Year:
- -41%
RETURN ON EQUITY
- 10 Years:
- -58%
- 5 Years:
- -118%
- 3 Years:
- -160%
- Last Year:
- -499%
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 12 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 |
| 13 | 11 | 15 | 15 | 5 | 2 | -8 | -6 | -6 | -16 | |
| 9 | 11 | 9 | 19 | 17 | 19 | 20 | 21 | 24 | 34 | |
| Trade Payables | 2 | 4 | 2 | 5 | 11 | 7 | 9 | 10 | 7 | 7 |
| 5 | 7 | 6 | 7 | 5 | 6 | 8 | 9 | 4 | 4 | |
| Total Liabilities | 34 | 46 | 44 | 58 | 51 | 47 | 42 | 46 | 42 | 43 |
| 15 | 17 | 20 | 26 | 25 | 26 | 24 | 23 | 22 | 22 | |
| Capital Work in Progress | 0 | 0 | 2 | 2 | 3 | 0 | 1 | 1 | 2 | 0 |
| 2 | 2 | 3 | 7 | 7 | 3 | 7 | 9 | 9 | 10 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 8 | |
| Cash & Bank | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 16 | 26 | 19 | 23 | 16 | 17 | 9 | 13 | 4 | 2 | |
| Total Assets | 34 | 46 | 44 | 58 | 51 | 47 | 42 | 46 | 42 | 43 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 4 | 4 | 8 | -1 | 4 | -0 | 1 | -0 | 2 | -7 | |
| Cash from Investing | -1 | -4 | -5 | -8 | -2 | 0 | -1 | -1 | -1 | -1 |
| Cash from Financing | -4 | 2 | -1 | 9 | -2 | 1 | -1 | 1 | -2 | 9 |
| -1 | -0 | 1 | -0 | 0 | 0 | -0 | 0 | -0 | 0 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| PER SHARE | ||||||||||
| EPS (₹) | 69.84 | 4.97 | 1.38 | 0.05 | -7.70 | -2.16 | -7.52 | 0.90 | 0.05 | -7.25 |
| Book Value (₹) | 370.02 | 19.41 | 21.46 | 21.50 | 13.81 | 11.65 | 4.13 | 5.03 | 5.08 | -2.17 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash EPS (₹) | 3.65 | 5.91 | 2.38 | 1.32 | -6.33 | -0.75 | -6.12 | 2.30 | 1.41 | -5.80 |
| PROFITABILITY | ||||||||||
| Operating Margin % | 26.98% | 29.26% | 16.05% | 8.63% | -29.88% | -0.84% | -29.75% | 9.55% | 11.03% | -16.11% |
| Net Margin % | 12.10% | 16.37% | 6.82% | 0.19% | -32.64% | -10.43% | -44.79% | 2.63% | 0.15% | -24.44% |
| ROE % | 20.84% | 29.06% | 6.94% | 0.23% | -43.60% | -16.97% | -95.27% | 19.60% | 0.95% | -499.06% |
| ROCE % | 23.24% | 31.84% | 8.03% | 2.72% | -24.74% | -3.37% | -23.27% | 8.73% | 10.10% | -22.89% |
| 10.81% | 15.07% | 3.93% | 0.12% | -18.04% | -5.60% | -21.62% | 2.60% | 0.14% | -21.97% | |
| EFFICIENCY | ||||||||||
| Debtor Days | 80 | 118 | 169 | 120 | 126 | 119 | 95 | 33 | 49 | 64 |
| Inventory Days | 24 | 22 | 36 | 55 | 81 | 70 | 86 | 64 | 78 | 88 |
| Payable Days | 61 | 93 | 163 | 128 | 150 | 213 | 191 | 135 | 150 | 97 |
| 43 | 47 | 42 | 47 | 57 | -24 | -10 | -38 | -23 | 55 | |
| FINANCIAL HEALTH | ||||||||||
| Debt to Equity (x) | 0.59x | 0.54x | 0.35x | 0.76x | 1.11x | 1.57x | 4.62x | 4.19x | 4.03x | -12.98x |
| Interest Coverage (x) | 5.38x | 12.10x | 3.81x | 1.05x | -7.74x | -0.97x | -4.68x | 1.71x | 1.82x | -4.38x |
| 1.37x | 1.40x | 1.72x | 1.58x | 0.92x | 1.11x | 0.72x | 0.86x | 1.14x | 0.90x | |
| GROWTH | ||||||||||
| Revenue Growth % | 38.13% | 33.28% | -27.03% | 26.60% | -6.85% | -12.18% | -18.97% | 103.64% | -8.25% | -5.42% |
| Operating Profit Growth % | -1.19% | 42.59% | -61.35% | -32.77% | -422.66% | 97.54% | -2776.32% | 165.35% | 21.58% | -213.51% |
| Net Profit Growth % | -15.04% | 77.91% | -70.62% | -96.49% | 0.00% | 71.94% | -248.05% | 111.94% | -94.64% | 0.00% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -94.64% | 0.00% | |
| VALUATION | ||||||||||
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 644.49x | 0.00x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 6.11x | -12.09x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 12.88x | -11.99x |
Documents
Corporate disclosures, annual reports, credit ratings, and concall transcripts
No announcements filed.
News
Recent coverage and analyst commentary for VSCL
Loading news…
AI Stock Analyst
Vadivarhe Speciality Chemicals Ltd.
Sign in to Chat with AI
Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.
✨ Sign In to ChatFree 5nance Account

